Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.

AIDS research and human retroviruses - 1 Jun 2015

Chin Bum Sik, Shin Hyoung-Shik, Kim Gayeon, Wagner Gabriel A, Gianella Sara, Smith Davey M

Abstract excerpt

Previous studies reported a relatively low prevalence of transmitted drug resistance (TDR) in South Korea (<5%). A genotypic resistance test was performed on 131 treatment-naive HIV-1-infected individuals from February 2013 to February 2014. Eleven individuals (8.4%) presented TDR, of whom eight had K103N, revealing a significant increase in K103N TDR compared to previous studies (p<0.001). Using phylogenetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzoxazines

Share to Cyclopropanes

Share to Drug Resistance, Viral

Share to HIV Reverse Transcriptase

Share to Incidence

Share to Republic of Korea

Source

Open in PubMed Open full text

Identifiers

PMID: 25826122
DOI: 10.1089/AID.2014.0368
PMCID: PMC4516954

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.PMID 25826122Read ↗

Transmission network of an HIV type 1 strain with K103N in young Belgian patients from different risk groups.Semantic proximity Read ↗

Short Communication: Trends in Transmitted Drug Resistance in Treatment-Naive HIV Patients in Korea.Semantic proximity Read ↗

Surveillance of HIV-1 drug resistance in Xinjiang: high prevalence of K103N in treatment-naïve individuals.Semantic proximity Read ↗

National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005.Semantic proximity Read ↗

Mutations other than 103N in human immunodeficiency virus type 1 reverse transcriptase (RT) emerge from K103R polymorphism under non-nucleoside RT inhibitor pressure.Semantic proximity Read ↗

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island.Semantic proximity Read ↗

Rare mutations at codon 103 of HIV-1 reverse transcriptase can confer resistance to non-nucleoside reverse transcriptase inhibitors.Semantic proximity Read ↗

Low prevalence of drug-resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea.Semantic proximity Read ↗

Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea.Semantic proximity Read ↗

Prevalence of primary antiretroviral resistance: trends in Korea.Semantic proximity Read ↗

Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active antiretroviral therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.